LungLife AI (LSE:LLAI) FCF Yield % : -69.22 (As of May. 27, 2024)

View and export this data going back to 2021. Start your Free Trial

What is LungLife AI FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, LungLife AI's Trailing 12-Month Free Cash Flow is £-4.03 Mil, and Market Cap is £5.83 Mil. Therefore, LungLife AI's FCF Yield % for today is -69.22%.

The historical rank and industry rank for LungLife AI's FCF Yield % or its related term are showing as below:

LSE:LLAI' s FCF Yield % Range Over the Past 10 Years
Min: -97.99 Med: -26.72 Max: -4.15
Current: -69.22

During the past 6 years, the highest FCF Yield % of LungLife AI was -4.15%. The lowest was -97.99%. And the median was -26.72%.

LSE:LLAI's FCF Yield % is ranked worse than
87.93% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.815 vs LSE:LLAI: -69.22

LungLife AI's FCF Margin % for the quarter that ended in Dec. 2023 was -10,500.00%.

LungLife AI FCF Yield % Historical Data

The historical data trend for LungLife AI's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI FCF Yield % Chart

LungLife AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-14.74

-22.48

-34.35

LungLife AI Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial					-18.74	-14.71	-19.57	-65.92	-32.24

Competitive Comparison of LungLife AI's FCF Yield %

For the Diagnostics & Research subindustry, LungLife AI's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LungLife AI's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's FCF Yield % distribution charts can be found below:

* The bar in red indicates where LungLife AI's FCF Yield % falls into.

LungLife AI FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

LungLife AI's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-4.027	/	11.72356
	=	-34.35%

LungLife AI's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-1.89	*	2	/	11.72356
	=	-32.24%

LungLife AI FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

LungLife AI FCF Yield % Related Terms

Thank you for viewing the detailed overview of LungLife AI's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

LungLife AI (LSE:LLAI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320

Website

https://www.lunglifeai.com

LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines